Inactive Instrument

Allkem

Equities

AKE

AU0000193666

Allkem Limited Reports Earnings Results for the Full Year Ended June 30, 2022

August 24, 2022 at 11:06 pm

Allkem Limited reported earnings results for the full year ended June 30, 2022. For the full year, the company reported sales was USD 769.82 million compared to USD 84.76 million a year ago. Net income was USD 305.67 million compared to net loss of USD 59.63 million a year ago.

Basic earnings per share from continuing operations was USD 0.5159 compared to basic loss per share from continuing operations of USD 0.1802 a year ago. Diluted earnings per share from continuing operations was USD 0.5134 compared to diluted loss per share from continuing operations of USD 0.1802 a year ago.

Latest news about Allkem

Allkem to be Delisted from Toronto Bourse	01-05	MT
Allkem to be Removed from Australian Bourse's Official List	01-05	MT
Arcadium Lithium plc Appoints Paul W. Graves as Chief Executive Officer	01-04	CI
Arcadium Lithium plc Appoints Gilberto Antoniazzi as Chief Financial Officer	01-04	CI
Livent Corporation, Livent USA Corp., Arcadium Lithium Plc, Arcadium Lithium Financing IRL Limited and Irish IntermediateCo Enter into A Joinder and First Amendment to Certain Amended and Restated Credit Agreement with Citibank, N.A	01-04	CI
Allkem Says COMEX Approval Granted for James Bay	12-28	MT
North American Morning Briefing : S&P 500 Futures Just Shy of Record High	12-28	DJ
Allkem Secures Environmental Approval for James Bay Project Development	12-28	MT
Arcadium Lithium's Scheme to Acquire Allkem Takes Effect	12-26	MT
Allkem Limited(ASX:AKE) dropped from S&P Global BMI Index	12-22	CI
Allkem Limited(ASX:AKE) dropped from S&P/ASX 100 Index	12-22	CI
Allkem Limited(ASX:AKE) dropped from S&P/ASX 200 Materials Sector Index	12-22	CI
Allkem Limited(ASX:AKE) dropped from S&P/ASX 200 Index	12-22	CI
Allkem Limited(ASX:AKE) dropped from S&P/ASX All Ordinaries Index	12-22	CI
Allkem Limited(ASX:AKE) dropped from S&P/ASX 300 Index	12-22	CI
Livent, Allkem Shareholders Approve $10.6 Billion Merger	12-19	MT
Global markets live: Apple, AbbVie, Comcast, FMC Accenture...	12-19
Investors got more clues that rate cuts are imminent	12-19
Livent Secures Allkem Shareholders' Approval for Planned Business Combination	12-19	MT
Allkem Limited Brief: Said Shareholders Vote in Favour of Merger with Livent	12-19	MT
Allkem shareholders vote in favour of $10.6 bln Livent merger	12-19	RE
Allkem investors approve Livent $10.6 bln merger on proxy votes	12-19	RE
Transcript : Allkem Limited - Shareholder/Analyst Call	12-19
Allkem shareholders set to vote on Livent's $10.6 bln merger bid	12-18	RE
Allkem Signs Kapisikama Agreement to Develop James Bay Lithium Project	12-15	MT

Chart Allkem

Duration

Period

More charts

Company Profile

Allkem Limited is a specialty lithium chemicals company with a global portfolio of lithium chemicals. The Company is principally engaged in mineral extraction, production, and chemical processing. The Company's segments include Olaroz, Mt Cattlin, James Bay, Sal De Vida projects, and Corporate. Its flagship Olaroz brine-based lithium facility is based in Northern Argentina and supplies lithium chemicals across the globe. The Mt Cattlin spodumene project (Mt Cattlin) produces spodumene concentrate utilizing conventional techniques to extract and process the resource. This wholly owned project is located two kilometers (km) north of the town of Ravensthorpe in Western Australia. The James Bay Project is located in northern Quebec, approximately 130 km east of James Bay and the Cree Nation of Eastmain community. Sal De Vida project is a tier one brine project, which is located in Catamarca Province on the Salar del Hombre Muerto. Its other project includes Cauchari mineral resource.

Sector

More about the company